Azenta Q4 ’23 Earnings Release Conference Call and Webcast
November 13, 2023 at 4:30 PM EDT
Stephens Annual Investment Conference
November 15-16, 2023
Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint.
View our latest investor presentation
Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in 1x1 meetings at the 6th Annual Evercore ISI HealthCONx Conference in Miami, FL, on Wednesday, November 29, 2023.
Q4'23 reported revenue growth of 25% year over year and 2% on an organic basis FY'23 reported revenue growth of 20% and down 1% on an organic basis Q4'23 generated positive free cash flow for the...
Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven of the Board of Directors' ten members will have been added...
Head of Investor Relations & Corporate Communications
Executive Assistant to CFO
P.O. Box 43006
Providence RI 02940-3006
Investor Center web address:
SIGN UP FOR ALERTS AND NEVER MISS INVESTOR UPDATES!